SCHEMBL10012415

SCHEMBL10012415

N#CCCC(CC(=O)O)C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 1/20 0.60
FOLH1 Q04609 5/20 0.56
CPA1 P15085 2/20 0.38
CPB1 P15086 1/20 0.38
CPA3 P15088 1/20 0.38
CPB2 Q96IY4 1/20 0.38
TDP1 Q9NUW8 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.36
CHRM1 P11229 1/20 0.34
AKR1A1 P14550 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
ADRA1A P35348 1/20 0.34
HRH1 P35367 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
SLC22A6 Q4U2R8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12212883 0.86 SLC1A2 (0.69) SLC1A2FOLH1TDP1CHRM1AKR1A1
SCHEMBL29530823 0.81 SLC1A2 (0.58) SLC1A2FOLH1
SCHEMBL2147491 0.80 SLC1A2 (0.62) SLC1A2FOLH1CPB2TDP1CHRM1
SCHEMBL27930116 0.80 SLC1A2 (0.62) SLC1A2FOLH1TDP1CHRM1AKR1A1
SCHEMBL11657709 0.78 SLC1A2 (0.60) SLC1A2FOLH1TDP1CHRM1AKR1A1
SCHEMBL10668071 0.78 FOLH1 (0.56) SLC1A2FOLH1CPA1CPB1CPA3
SCHEMBL18663874 0.78 SLC1A2 (0.60) SLC1A2TDP1CHRM1AKR1A1CHRM3
SCHEMBL164322 0.78 FOLH1 (0.75) FOLH1CPA1CPB1CPA3CPB2
SCHEMBL21802279 0.78 FOLH1 (0.75) FOLH1CPA1CPB1CPA3CPB2
SCHEMBL7350597 0.77 FOLH1 (0.48) SLC1A2FOLH1CPA1CPB1CPA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME UBE INDUSTRIES, LTD. (JP) 2012-07-05 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120171581-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME SLC8A1, OR10J3, SLC8B1 SLC1A2 195/4885FOLH1 4316/4885CPA1 1779/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.